Human Immunodeficiency Virus Type 1 Virion Density Is Not Determined by Nucleocapsid Basic Residues

ABSTRACT The human immunodeficiency virus type 1 (HIV-1) Gag polyprotein is sufficient for assembly and release of virion-like particles from the plasma membrane. To promote assembly, the Gag polyprotein must polymerize to form a shell that lines the inner membrane of nascent virions. Several techniques have been used to functionally map the domain required for Gag polymerization (the I domain). Among these methods, isopycnic centrifugation has been used under the assumption that changes in virion density reflect impairment in Gag-Gag interaction. If virion density is determined by efficient Gag-Gag interaction, then mutation of basic residues in the nucleocapsid (NC) domain should disrupt virion density, since these residues constitute the I domain. However, we have previously shown that simultaneous disruption of up to 10 HIV-1 NC basic residues has no obvious effect on virion density. To rule out the possibility that HIV-1 NC basic residues other than those previously mutated might be important for virion density, mutations were introduced at the remaining sites and the ability of these mutations to affect Gag-Gag interaction and virion density was analyzed. Included in our analysis is a mutant in which all NC basic residues are replaced with alanine. Our results show that disruption of HIV-1 NC basic residues has an enormous effect on Gag-Gag interaction but only a minimal effect on the density of those virions that are still produced. Therefore, the determinants of the I domain and of virion density are genetically distinguishable.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Luban,et al.  Basic Residues in Human Immunodeficiency Virus Type 1 Nucleocapsid Promote Virion Assembly via Interaction with RNA , 2000, Journal of Virology.

[3]  J. Luban,et al.  Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein , 1999, Journal of Virology.

[4]  V. Vogt,et al.  Mass Determination of Rous Sarcoma Virus Virions by Scanning Transmission Electron Microscopy , 1999, Journal of Virology.

[5]  J. Luban,et al.  Translation Elongation Factor 1-Alpha Interacts Specifically with the Human Immunodeficiency Virus Type 1 Gag Polyprotein , 1999, Journal of Virology.

[6]  J. Lifson,et al.  Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo. , 1999, Virology.

[7]  L. Dawson,et al.  The role of nucleocapsid of HIV-1 in virus assembly. , 1998, Virology.

[8]  E. Freed,et al.  HIV-1 gag proteins: diverse functions in the virus life cycle. , 1998, Virology.

[9]  A. Rein,et al.  Importance of Basic Residues in the Nucleocapsid Sequence for Retrovirus Gag Assembly and Complementation Rescue , 1998, Journal of Virology.

[10]  P. Spearman,et al.  The I Domain Is Required for Efficient Plasma Membrane Binding of Human Immunodeficiency Virus Type 1 Pr55Gag , 1998, Journal of Virology.

[11]  A. Aldovini,et al.  Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity , 1996, Journal of virology.

[12]  E. Barklis,et al.  Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents , 1996, Journal of virology.

[13]  H. Zentgraf,et al.  The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity , 1995, Journal of virology.

[14]  B. Gay,et al.  Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles , 1995, Journal of virology.

[15]  A. Kaplan,et al.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions , 1994, Journal of virology.

[16]  J. Sodroski,et al.  Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.

[17]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[18]  J. Luban,et al.  Specificity and sequence requirements for interactions between various retroviral Gag proteins , 1994, Journal of virology.

[19]  O. Haffar,et al.  Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Wills,et al.  Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins , 1993, Journal of virology.

[21]  Jeremy Luban,et al.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.

[22]  A. Smith,et al.  Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles , 1993, Journal of virology.

[23]  Deborah A. Brown,et al.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.

[24]  R. Gorelick,et al.  Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Gilcher Ro Human retroviruses and AIDS. , 1988 .

[26]  Arthur Weiss,et al.  The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. , 1984, Journal of immunology.

[27]  J. Mccormick,et al.  Hydrodynamic diameters of RNA tumor viruses. Studies by laser beat frequency light scattering spectroscopy of avian myeloblastosis and Rauscher murine leukemia viruses. , 1975, Biochemistry.

[28]  S. Goff,et al.  Reverse Transcriptase and the Generation of Retroviral DNA , 1997 .

[29]  R. Swanstrom,et al.  Synthesis, Assembly, and Processing of Viral Proteins , 1997 .

[30]  D. Rickwood Preparative centrifugation : a practical approach , 1992 .

[31]  R. Gilcher Human retroviruses and AIDS. , 1988, The Journal of the Oklahoma State Medical Association.